Download PDF
Erfahrungsheilkunde 2014; 63(6): 325-331
DOI: 10.1055/s-0034-1395804
Wissen
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Rhodiola rosea bei Chronic Fatigue Syndrom

Achtwöchige, dokumentierte Anwendungsbeobachtung mit 28 Teilnehmern
Sebastian Vigl
Further Information

Publication History

Publication Date:
16 December 2014 (online)

    Permissions and Reprints

Zusammenfassung

In der 8-wöchigen Anwendungsbeobachtung „Rhodiolan® 200 bei ME/CFS“ wurde der Nutzen eines Rosenwurzpräparats für Patienten, die am Chronic Fatigue Syndrom leiden, ermittelt. Aufgrund der bekannten adaptogenen Wirkung von Rhodiola rosea standen hierbei kognitive Beschwerden im Fokus des Interesses. Bei den beobachteten Symptomen waren v.a. die Besserung der Konzentrationsfähigkeit und der mentalen Belastbarkeit bedeutsam, das Präparat wurde gut vertragen.

Abstract

In the present study the efficacy and tolerability of Rhodiola root extract SHR-5 (Rhodiolan® 200) in patient with chronic fatigue syndrom (ME, CFS) was investigated. Because of the adaptogen characteristics of Rhodiola rosea the main focus was placed on cognitive symptoms. The remedy was well tolerated and showed a remarkable increase in power of concentration and mental capacity.

Schlüsselwörter

Rosenwurz - Rhodiola rosea - Fatigue - ME - CFS

Keywords

Arctic root - Rhodiola rosea - fatigue - ME - CFS
 

  • Literatur

  • 1 Carruthers BM et al Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome 2003; 11: 7-36
    PubMedGoogle Scholar
  • 2 Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol 2009; 4: 198-219
    CrossrefPubMedGoogle Scholar
  • 3 Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind,placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 2009; 75: 105-112
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Spasov AA, Wikman GK, Mandrikov VB et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000; 7: 85-89
    CrossrefPubMedGoogle Scholar
  • 5 Darbinyan V, Kteyan A, Panossian A et al. Rhodiola rosea in stress induced fatigue − a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000; 7: 365-371
    CrossrefPubMedGoogle Scholar
  • 6 Darbinyan V, Aslanyan G, Amroyan E et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 2007; 61: 503
    CrossrefPubMedGoogle Scholar
  • 7 Grünwald J, Stier H, Bruhn S et al. Rhodiola rosea: Ein Adaptogen bei Burn-out. Z Phytother 2011; 32: 161-163
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Vigl S. Das chronische Erschöpfungssyndrom (ME/CFS). Über die Studienlage zu einzelnen Vitalpilzen und Heilpflanzen. Naturheilpraxis 2013; 7: 25-27
    PubMedGoogle Scholar
  • 9 Goyvaerts B, Bruhn S. Rhodiola-rosea-Spezialextrakt SHR-5 bei Burn-out und Erschöpfungssyndrom. Ergebnisse einer Praxisstudie zur Wirksamkeit. EHK 2012; 61: 79-83
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Bell DS. The Doctor’s Guide to Chronic Fatigue Syndrome: Understanding, Treating and Living with CFIDS. Reading: Addison Wesley Longman Pub. Co.; 1993
    Google Scholar